Synchronous apoptosis in established tumors leads to the induction of adaptive immunity.

about

Trial Watch:: Oncolytic viruses for cancer therapy The dual role of NK cells in antitumor reactions triggered by ionizing radiation in combination with hyperthermia Consensus guidelines for the detection of immunogenic cell death.Trial Watch: Radioimmunotherapy for oncological indications.

P2860

Q27021951-E9EA3225-1B33-4E2A-8E1E-6E5805FDEC4B Q42427640-FA4DC618-9367-4A97-9A64-B22892069361 Q42553556-2516A159-2FD3-45AB-A712-4F5229BE3754 Q43104064-8EB60E5E-0819-483F-AE08-7246E3AAEDA2

P2860

Synchronous apoptosis in established tumors leads to the induction of adaptive immunity.

Item

http://www.wikidata.org/entity/Q43084704

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Synchronous apoptosis in established tumors leads to the induction of adaptive immunity.

@en

Synchronous apoptosis in established tumors leads to the induction of adaptive immunity.

@nl

type

Item

label

Synchronous apoptosis in established tumors leads to the induction of adaptive immunity.

@en

Synchronous apoptosis in established tumors leads to the induction of adaptive immunity.

@nl

prefLabel

Synchronous apoptosis in established tumors leads to the induction of adaptive immunity.

@en

Synchronous apoptosis in established tumors leads to the induction of adaptive immunity.

@nl

P1476

Synchronous apoptosis in established tumors leads to the induction of adaptive immunity.

@en

P2093

Jamie Honeychurch

http://www.w3.org/2001/XMLSchema#string

P2860

Calreticulin exposure dictates the immunogenicity of cancer cell death

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

Corpse clearance defines the meaning of cell death.

Apoptotic cell removal in development and tissue homeostasis.

Trial watch: Prognostic and predictive value of the immune infiltrate in cancer

Sustained tumour eradication after induced caspase-3 activation and synchronous tumour apoptosis requires an intact host immune response

Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy.

Generation of cells expressing improved doxycycline-regulated reverse transcriptional transactivator rtTA2S-M2.

Generation of constitutively active recombinant caspases-3 and -6 by rearrangement of their subunits.

P304

e24501

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/ONCI.24501

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Caroline Dive

Tim M. Illidge

P577

2013-04-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

253336767

http://www.w3.org/2001/XMLSchema#string

P698

23894711

http://www.w3.org/2001/XMLSchema#string

P932

3716746

http://www.w3.org/2001/XMLSchema#string

Synchronous apoptosis in established tumors leads to the induction of adaptive immunity.

about

P2860

P2860

Synchronous apoptosis in established tumors leads to the induction of adaptive immunity.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932